Dr. Ankit Bhardwaj is presently working as a Jr Clinical Trial Coordinator in Department of Clinical Research at ILBS. He has done PhD in Epidemiology. He is managing all clinical trials (both internal as well external undergoing projects). He is helping the DM/PDCC students for their research protocol. He is responsible for smooth conduction of global as well as inhouse clinical trials He is also acting as liaison officer between Institute and the various external pharmaceuticals companies. He has vast experience of handing Internal & External Sponsor audits. He has created the facility of an IWRS-based randomization method for in-house Clinical Trials and ILBS e-Pro, an electronic data-capturing facility for academic trials at ILBS.

• Total Number of publications : 38
• Total Number of publications in 2023 : 05

Conferences attended:

• AASLD Oral Presentation 2013 (Washington, USA) :
  Bhardwaj A, Kumar C, Kumar M, Sarin SK. A prospective double-blind, randomized placebo controlled trial of carvedilol for early primary prophylaxis of esophageal varices in cirrhosis (Clinicaltrials.gov no: NCT01196507).
• AASLD Oral Presentation 2014 (Boston, USA) :
  Bhardwaj A, Kumar C, Jindal A, Sarin SK. A prospective, open labeled, randomized controlled trial comparing Carvedilol + VSL#3 versus EVL for primary prophylaxis of esophageal variceal bleeding in cirrhotic patients non-responder to carvedilol (Clinicaltrials.gov no: NCT01196481).
• ISG Poster Presentation 2014 (Presidential Poster) (Mumbai, India) :
  Bhardwaj A, Kumar C, Kumar M, Sarin SK. Efficacy of carvedilol in early primary prophylaxis of esophageal varices in cirrhosis- a double blind randomized placebo-controlled trial (Clinicaltrials.gov no: NCT01196507).
• AASLD Poster Presentation 2016 (Boston, USA) :
  Frequency and Profile of decompensation in cirrhotics with Hepatic Venous Pressure Gradient below 10 mm Hg: Need to redefine CSPH.
• APASL Oral Presentation 2018 (New Delhi, India) :
  Plenary Presentation “Natural history of patients with compensated cirrhosis and a Hepatic Venous Pressure Gradient >20 mm Hg: A Prospective longitudinal Cohort Study” in APASL 2018, New Delhi, India.